SensiScreen® FFPE KRAS qPCR Assay is an in vitro diagnostic assay for sensitive detection, identification and quantification of KRAS mutations.
- 0.2-1.9% limit of detection (LOD)
- Run Time in less than 2 hours
- Based on INA® technology
- Ready-to-Use optionality
- Minimal hands-on time
- Open platform design*
Link to product details on PentaBase.com – Click here –
Link to IFU – Click here –